200 related articles for article (PubMed ID: 35849970)
1. Artesunate: A review of its therapeutic insights in respiratory diseases.
Zhang J; Li Y; Wan J; Zhang M; Li C; Lin J
Phytomedicine; 2022 Sep; 104():154259. PubMed ID: 35849970
[TBL] [Abstract][Full Text] [Related]
2. Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma.
Ho WE; Cheng C; Peh HY; Xu F; Tannenbaum SR; Ong CN; Wong WS
Free Radic Biol Med; 2012 Aug; 53(3):498-507. PubMed ID: 22634146
[TBL] [Abstract][Full Text] [Related]
3. The antimalarial drug artesunate inhibits primary human cultured airway smooth muscle cell proliferation.
Tan SS; Ong B; Cheng C; Ho WE; Tam JK; Stewart AG; Harris T; Wong WS; Tran T
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):451-8. PubMed ID: 24066853
[TBL] [Abstract][Full Text] [Related]
4. The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells.
Zheng L; Pan J
Curr Cancer Drug Targets; 2018; 18(10):988-998. PubMed ID: 29692251
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of medications used for viral infection-induced respiratory diseases.
Yamaya M; Kikuchi A; Sugawara M; Nishimura H
Respir Investig; 2023 Mar; 61(2):270-283. PubMed ID: 36543714
[TBL] [Abstract][Full Text] [Related]
6. Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice.
Ng DS; Liao W; Tan WS; Chan TK; Loh XY; Wong WS
Phytomedicine; 2014 Oct; 21(12):1638-44. PubMed ID: 25442271
[TBL] [Abstract][Full Text] [Related]
7. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.
Cheng C; Ng DS; Chan TK; Guan SP; Ho WE; Koh AH; Bian JS; Lau HY; Wong WS
Allergy; 2013 Feb; 68(2):195-203. PubMed ID: 23253152
[TBL] [Abstract][Full Text] [Related]
8. Artesunate attenuates airway resistance in vivo and relaxes airway smooth muscle cells in vitro via bitter taste receptor-dependent calcium signalling.
Wang Y; Wang A; Zhang M; Zeng H; Lu Y; Liu L; Li J; Deng L
Exp Physiol; 2019 Feb; 104(2):231-243. PubMed ID: 30379382
[TBL] [Abstract][Full Text] [Related]
9. The anti-malaria drug artesunate inhibits cigarette smoke and ovalbumin concurrent exposure-induced airway inflammation and might reverse glucocorticoid insensitivity.
Luo Q; Lin J; Zhang L; Li H; Pan L
Int Immunopharmacol; 2015 Dec; 29(2):235-245. PubMed ID: 26590116
[TBL] [Abstract][Full Text] [Related]
10. Repurposing Antimalarials to Tackle the COVID-19 Pandemic.
Krishna S; Augustin Y; Wang J; Xu C; Staines HM; Platteeuw H; Kamarulzaman A; Sall A; Kremsner P
Trends Parasitol; 2021 Jan; 37(1):8-11. PubMed ID: 33153922
[TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases.
Liao W; Dong J; Peh HY; Tan LH; Lim KS; Li L; Wong WF
Molecules; 2017 Jan; 22(1):. PubMed ID: 28106744
[TBL] [Abstract][Full Text] [Related]
12. Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells.
Ravindra KC; Ho WE; Cheng C; Godoy LC; Wishnok JS; Ong CN; Wong WS; Wogan GN; Tannenbaum SR
Chem Res Toxicol; 2015 Oct; 28(10):1903-13. PubMed ID: 26340163
[TBL] [Abstract][Full Text] [Related]
13. Nerve Growth Factor: A Potential Therapeutic Target for Lung Diseases.
Liu P; Li S; Tang L
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502019
[TBL] [Abstract][Full Text] [Related]
14. Exogenous Glutamine in Respiratory Diseases: Myth or Reality?
Oliveira GP; de Abreu MG; Pelosi P; Rocco PR
Nutrients; 2016 Feb; 8(2):76. PubMed ID: 26861387
[TBL] [Abstract][Full Text] [Related]
15. New Insights into Artesunate as a Pleiotropic Regulator of Innate and Adaptive Immune Cells.
Lin L; Tang Z; Shi Z; Guo Q; Xiong H
J Immunol Res; 2022; 2022():9591544. PubMed ID: 35178460
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic effects approach of essential oils and their components on respiratory diseases.
Li J; Chen W; Liu H; Liu H; Xiang S; You F; Jiang Y; Lin J; Zhang D; Zheng C
J Ethnopharmacol; 2023 Mar; 304():115962. PubMed ID: 36529244
[TBL] [Abstract][Full Text] [Related]
17. Developing PI3K Inhibitors for Respiratory Diseases.
Fagone E; Fruciano M; Gili E; Sambataro G; Vancheri C
Curr Top Microbiol Immunol; 2022; 436():437-466. PubMed ID: 36243856
[TBL] [Abstract][Full Text] [Related]
18. Molecular hydrogen is a promising therapeutic agent for pulmonary disease.
Fu Z; Zhang J
J Zhejiang Univ Sci B; 2022 Feb; 23(2):102-122. PubMed ID: 35187885
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
Zhang C; Li J; Wu Z; Wang H; Que C; Zhao H; Wang G
Trials; 2020 Jun; 21(1):495. PubMed ID: 32513299
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the antimalarial activity of artesunate.
Adebayo JO; Tijjani H; Adegunloye AP; Ishola AA; Balogun EA; Malomo SO
Parasitol Res; 2020 Sep; 119(9):2749-2764. PubMed ID: 32638101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
